Safety, tolerability and viral kinetics during SARS-CoV-2 human challenge
Covid19-Sources
‘Pandemic of the unboosted’: low US Covid jab uptake piles pressure on hospitals
Neutralization profile of Omicron variant convalescent individuals
Limited cross-variant immunity after infection with the SARS-CoV-2 Omicron variant without vaccination
COVID-19 reinfections among naturally infected and vaccinated individuals
Non-cell autonomous disruption of nuclear architecture as a potential cause of COVID-19 induced anosmia
Coronavirus (COVID-19) Infection Survey, characteristics of people testing positive for COVID-19, UK - Office for National Statistics
Face mask fit hacks: Improving the fit of KN95 masks and surgical masks with fit alteration techniques
Paper demonstrating Omicron's immune escape vs. vaccination and previous infection
Transmission of SARS-CoV-2 Omicron VOC subvariants BA.1 and BA.2: Evidence from Danish Households
In rare cases, coronavirus vaccines may cause Long Covid–like symptoms
German scientists researching nasal spray COVID vaccination
%2Fcloudfront-us-east-2.images.arcpublishing.com%2Freuters%2FTHVEYKGLTRO2VEGBZ6S4RQRINM.jpg?width=92&height=&ar=&mode=&format=avif&dpr=2)
Easier to produce COVID vaccine shows promise in trials; nasal spray vaccine booster works in mice
Bharat Biotech seeks nod for phase-3 clinical trials of nasal vaccine
Historically High Excess Mortality During the COVID-19 Pandemic in Switzerland, Sweden, and Spain
Even More Safety and Effectiveness Data for COVID-19 Vaccines for Children
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2 - 41422_2020_Article_387.pdf
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial
Insights from a computational analysis of the SARS-CoV-2 Omicron...
A Phase III Confirmatory Study of K-237 - Full Text View
Evidence for a role of phenotypic mutations in virus adaptation
Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies - 2021.07.29.21261282v2.full.pdf
Progressive Increase in Virulence of Novel SARS-CoV-2 Variants in Ontario, Canada - 2021.07.05.21260050v3.full.pdf
Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes
The interferon landscape along the respiratory tract impacts the severity of COVID-19
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
Pressemitteilungen - Antikörper nach SARS-CoV-2-Infektion – neue Erkenntnisse über die Sensitivität und Nachweisdauer von Antikörpertests
Executive dysfunction following SARS-CoV-2 infection: A cross-sectional examination in a population-representative sample
2021-12-21 COVID-19 Dashboard Briefing (all-MP call) - COVID-19_Data_Briefing__21_December_2021_.pdf